Excerpts

Although not statistically significant, our cohort observed a clear trend towards a higher mutational load in male patients, which goes in line with previously published data [ 28 ].

Nevertheless, RG2 cells showed a trend of forming more colonies than RG0 and RG1 despite no statistical significance given ( Figure 3 B-b).

The bias assessment of the studies that investigated mixed interventions showed a trend towards high risk for bias (one trial with “low”, two trials with “some concerns” and three trials with high risk of bias).

One study including 108 multiple myeloma patients that underwent autologous stem cell transplantation showed a trend towards progression-free survival in patients with immunoglobulin recovery compared to patients with immunoparesis.

Regression analysis using data from Global Burden of Disease 2019 determined the age-standardized rates of incidence (ASIRs) and mortality in 60 countries from 2000 through 2019 and found that 21 countries showed an increasing incidence of breast cancer in women aged <40 years, while 16 countries demonstrated a decreasing trend [ 25 ].

Overall, there was a decreasing trend in the incidence and mortality rates of ovarian cancer globally.

All SIMs separated the survival curves considerably, except pre-treatment PLR which showed marginal significance for OS.

Compared to developed countries, there is a higher breast cancer incidence rate among young women from low- and middle-income countries (LMIC), while the incidence rates show an increasing trend in LMICs.

Although the study did not meet its primary endpoint of PFS in the intention-to-treat (ITT) population, it has been observed a favorable PFS impact of atezolizumab in the subgroup of patients with PD-L1-positive (or with TILs ≥ 5%) tumors, along with a positive trend in terms of OS advantage [ 31 ].

We did not identify a positive trend for the accumulation of such variants among MMS patients, since only 15% of them were carriers of putatively damaging RNF213 variants, localized to the N-terminal region with a frequency similar to that found in the Biogear dataset (11%; p = 0.58).

An orthotopic model of skin SCC showed the lack of expansion of cancer-associated fibroblasts (CAFs) due to NOTCH1 gene silencing, without affecting the integrity of normal fibroblasts, and this may be significant for patients with a higher risk of skin carcinomas because of immune-suppressive therapies [ 37 ].

Most of the highly significant gene changes seen at 10 days in both groups did not persist after 14 days of holiday from palbociclib or after 14 days of continued AP after palbociclib + AP treatment, though many genes were dysregulated in the Residual Effect cohort with large-magnitude fold-change values, albeit to lesser degrees of statistical significance ( Figure 2 B).

In the present study, hemoglobin levels ≤ 11.5 g/dL showed a trend for an association with worse survival on univariate analysis.

The difference with p < 0.05 was considered significant, and with p < 0.001 was considered highly significant. 3.

Important analyzing the six samples for metabolic and apoptotic values we found a positive correlation between apoptosis and glycolytic levels in the AML blast treated with both the ascorbate and ascorbate–buformin treatments (Pearson’s coefficient r = 0.7) ( p = 0.1) ( Figure 5 d); even if these results are not significant, which would probably be due to the low number of samples, there is a clear trend in line with our previous results. 3.8.

In EMILIA, median progression-free survival (PFS) and overall survival (OS) were significantly longer with T-DM1 versus lapatinib plus capecitabine [ 3 ]; in TH3RESA, median PFS was significantly improved and median OS showed a trend toward improvement with T-DM1 versus physician’s choice [ 4 ].

In the past five years, an increasing trend in patent filing has been observed, mainly in a few prominent countries, with a focus on the digitization of pathological images and AI technologies that support the critical role of pathologists.

No difference in survival outcomes was observed between patients with de novo MCL and patients with sMCL; by contrast, the presence versus absence of C-findings, which were used to define acute and chronic MCL, respectively, was highly significant, as acute MCL had an OS inferior to chronic MCL [ 9 ].

However, a recent Italian multicenter study [ 11 ] suggested a decreasing trend of diagnostic accuracy as time elapses from ERCP with biliary stent placements.

The pooled analysis identified increased FL risk with ever, former and current smoking, and a positive trend with longer duration of smoking, but no trend with increasing smoking frequency or pack-years.

The results of the pilot study provided information on the feasibility of using virtual reality equipment in this group of patients and showed a favorable trend of changes in the working memory in individual patients.

We were not able to document a significant influence of the first-line treatment in NET G3 patients on mOS, but there was a slight trend toward better survival with the use of STZ + FU (only used in pancreatic NET G3 patients) and temozolomide plus capecitabine as compared to platinum-containing combinations.

Within the stromal compartment, a highly significant reduction in the number of CD3+ T cells was observed post-chemotherapy.

Moreover, there is an increasing trend in the incidence of various types of cancer from year to year [ 1 ].

The cancer-free survival curves showed a trend in favor of the open surgery group ( p 0.45).